Swedbank AB Boosts Stock Position in Humana Inc. (NYSE:HUM)

Swedbank AB grew its holdings in Humana Inc. (NYSE:HUM) by 6.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 112,790 shares of the insurance provider’s stock after purchasing an additional 6,814 shares during the period. Swedbank AB’s holdings in Humana were worth $28,616,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds have also made changes to their positions in the company. State Street Corp lifted its holdings in Humana by 1.0% during the 3rd quarter. State Street Corp now owns 5,357,420 shares of the insurance provider’s stock valued at $1,701,582,000 after buying an additional 53,272 shares in the last quarter. FMR LLC raised its stake in shares of Humana by 23.4% during the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock valued at $1,073,387,000 after acquiring an additional 643,291 shares in the last quarter. Pzena Investment Management LLC boosted its holdings in shares of Humana by 8.1% in the third quarter. Pzena Investment Management LLC now owns 2,506,250 shares of the insurance provider’s stock valued at $793,830,000 after purchasing an additional 187,903 shares during the period. Ontario Teachers Pension Plan Board increased its holdings in Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after purchasing an additional 71,910 shares during the period. Finally, Sanders Capital LLC raised its position in Humana by 1.0% during the 3rd quarter. Sanders Capital LLC now owns 1,168,341 shares of the insurance provider’s stock valued at $370,060,000 after purchasing an additional 11,923 shares in the last quarter. 92.38% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

HUM has been the topic of several recent research reports. Oppenheimer dropped their target price on shares of Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a report on Thursday, October 3rd. Bank of America upgraded shares of Humana from an “underperform” rating to a “neutral” rating and increased their price objective for the company from $247.00 to $308.00 in a research note on Wednesday, November 6th. UBS Group lowered their target price on Humana from $380.00 to $250.00 and set a “neutral” rating for the company in a report on Friday, October 4th. Deutsche Bank Aktiengesellschaft dropped their target price on Humana from $349.00 to $250.00 and set a “hold” rating on the stock in a research report on Thursday, October 3rd. Finally, Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and reduced their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Nineteen investment analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, Humana has an average rating of “Hold” and an average target price of $297.68.

Humana Stock Performance

Shares of HUM opened at $296.88 on Friday. The stock has a 50-day moving average of $275.44 and a two-hundred day moving average of $303.07. The company has a debt-to-equity ratio of 0.67, a quick ratio of 1.76 and a current ratio of 1.76. The stock has a market cap of $35.75 billion, a P/E ratio of 26.30, a P/E/G ratio of 2.15 and a beta of 0.55. Humana Inc. has a one year low of $213.31 and a one year high of $406.46.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The firm had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. As a group, research analysts predict that Humana Inc. will post 16.11 EPS for the current year.

Insider Activity

In related news, insider Timothy S. Huval sold 3,703 shares of the business’s stock in a transaction on Tuesday, December 31st. The shares were sold at an average price of $256.26, for a total transaction of $948,930.78. Following the completion of the transaction, the insider now directly owns 8,181 shares in the company, valued at $2,096,463.06. The trade was a 31.16 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders own 0.32% of the company’s stock.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.